9000 Virginia Manor Road, Suite 200
Beltsville, Maryland 20705
Tel : (240) 399-4900
July 28, 2025
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
| Attention: | Tim Buchmiller |
| Re: | NextCure, Inc. | ||
| Registration Statement on Form S-3 | |||
| File No. 333-288763 | |||
| Acceleration Request | |||
| Requested Date: | July 29, 2025 | ||
| Requested Time: | 4:00 P.M., Eastern Time | ||
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, NextCure, Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), be accelerated so that the Registration Statement will become effective at 4:00 P.M., Eastern Time, on July 29, 2025, or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.
Please contact Kostian Ciko of Sidley Austin LLP at (212) 839-5450 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement.
| Very truly yours, | |
| /s/ Michael Richman | |
| Michael Richman | |
| Chief Executive Officer | |
| NextCure, Inc. |
| cc: | Steven Cobourn, NextCure, Inc. |
| Asher Rubin, Sidley Austin LLP | |
| Istvan A. Hajdu, Sidley Austin LLP |